Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV Infections | 54 | 2024 | 17337 | 1.650 |
Why?
|
Herpes Genitalis | 3 | 2012 | 149 | 0.980 |
Why?
|
CD4-Positive T-Lymphocytes | 16 | 2022 | 4366 | 0.870 |
Why?
|
HIV-1 | 22 | 2021 | 6858 | 0.730 |
Why?
|
Ribonucleotides | 3 | 2019 | 114 | 0.730 |
Why?
|
Deoxyribonucleotides | 2 | 2019 | 43 | 0.720 |
Why?
|
Dideoxynucleotides | 1 | 2019 | 13 | 0.690 |
Why?
|
Leukocytes, Mononuclear | 5 | 2021 | 1835 | 0.660 |
Why?
|
Acquired Immunodeficiency Syndrome | 8 | 2023 | 2197 | 0.630 |
Why?
|
Antiretroviral Therapy, Highly Active | 8 | 2023 | 1894 | 0.610 |
Why?
|
CD4 Lymphocyte Count | 8 | 2020 | 2567 | 0.610 |
Why?
|
Biostatistics | 1 | 2019 | 163 | 0.580 |
Why?
|
Anti-HIV Agents | 9 | 2023 | 4524 | 0.570 |
Why?
|
Herpesvirus 2, Human | 3 | 2012 | 191 | 0.520 |
Why?
|
Sexually Transmitted Diseases | 3 | 2009 | 661 | 0.490 |
Why?
|
ROC Curve | 2 | 2020 | 3575 | 0.480 |
Why?
|
Viral Load | 15 | 2023 | 3325 | 0.460 |
Why?
|
Anti-Retroviral Agents | 6 | 2023 | 1782 | 0.460 |
Why?
|
Risk-Taking | 2 | 2009 | 1037 | 0.430 |
Why?
|
CD8-Positive T-Lymphocytes | 10 | 2022 | 4571 | 0.400 |
Why?
|
Sexual Behavior | 6 | 2024 | 2187 | 0.390 |
Why?
|
HIV | 7 | 2016 | 1579 | 0.370 |
Why?
|
Tuberculosis | 3 | 2020 | 2015 | 0.350 |
Why?
|
Tuberculosis, Meningeal | 2 | 2021 | 47 | 0.350 |
Why?
|
Alcoholism | 3 | 2009 | 1972 | 0.340 |
Why?
|
Killer Cells, Natural | 8 | 2018 | 2191 | 0.330 |
Why?
|
T-Lymphocytes, Cytotoxic | 4 | 2020 | 1779 | 0.330 |
Why?
|
Central Nervous System Infections | 2 | 2023 | 61 | 0.320 |
Why?
|
Coitus | 1 | 2009 | 132 | 0.320 |
Why?
|
Sexual Partners | 5 | 2023 | 800 | 0.320 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 4 | 2019 | 206 | 0.310 |
Why?
|
AIDS Vaccines | 4 | 2019 | 896 | 0.310 |
Why?
|
HIV Antibodies | 5 | 2018 | 1302 | 0.290 |
Why?
|
Receptors, Fc | 3 | 2018 | 534 | 0.290 |
Why?
|
Vagina | 5 | 2022 | 841 | 0.270 |
Why?
|
Epidemics | 1 | 2012 | 512 | 0.270 |
Why?
|
Apoptosis | 7 | 2021 | 9476 | 0.250 |
Why?
|
Tanzania | 4 | 2012 | 1390 | 0.250 |
Why?
|
Models, Statistical | 1 | 2019 | 5073 | 0.240 |
Why?
|
Lactobacillus | 4 | 2022 | 212 | 0.230 |
Why?
|
AIDS-Related Opportunistic Infections | 2 | 2020 | 662 | 0.230 |
Why?
|
HLA-B Antigens | 3 | 2019 | 317 | 0.220 |
Why?
|
Receptors, KIR | 6 | 2016 | 110 | 0.220 |
Why?
|
Lymphocyte Subsets | 2 | 2016 | 310 | 0.210 |
Why?
|
Histocompatibility Antigens Class I | 3 | 2022 | 1348 | 0.210 |
Why?
|
Immunization, Passive | 2 | 2016 | 616 | 0.210 |
Why?
|
Mycobacterium tuberculosis | 5 | 2019 | 1914 | 0.210 |
Why?
|
Statistics, Nonparametric | 1 | 2008 | 2849 | 0.200 |
Why?
|
Humans | 97 | 2024 | 760617 | 0.200 |
Why?
|
Epitopes | 3 | 2022 | 2501 | 0.200 |
Why?
|
B-Lymphocyte Subsets | 1 | 2023 | 238 | 0.200 |
Why?
|
T-Lymphocytes, Regulatory | 4 | 2021 | 3077 | 0.190 |
Why?
|
Heterosexuality | 1 | 2023 | 309 | 0.190 |
Why?
|
Head and Neck Neoplasms | 5 | 2014 | 2894 | 0.190 |
Why?
|
Ghana | 2 | 2020 | 315 | 0.190 |
Why?
|
Epoxide Hydrolases | 1 | 2021 | 122 | 0.180 |
Why?
|
Cytotoxicity, Immunologic | 4 | 2018 | 1349 | 0.180 |
Why?
|
Homosexuality, Male | 3 | 2024 | 1333 | 0.180 |
Why?
|
HLA-C Antigens | 3 | 2016 | 140 | 0.180 |
Why?
|
Viremia | 3 | 2019 | 707 | 0.170 |
Why?
|
Vaginosis, Bacterial | 1 | 2022 | 151 | 0.170 |
Why?
|
Immunity, Humoral | 2 | 2016 | 600 | 0.170 |
Why?
|
Immunoglobulin G | 5 | 2020 | 4533 | 0.170 |
Why?
|
Zambia | 4 | 2023 | 262 | 0.160 |
Why?
|
Host-Pathogen Interactions | 3 | 2019 | 1454 | 0.160 |
Why?
|
Premature Birth | 2 | 2021 | 1782 | 0.160 |
Why?
|
Awards and Prizes | 1 | 2023 | 360 | 0.160 |
Why?
|
Female | 57 | 2023 | 392148 | 0.160 |
Why?
|
Antibodies, Neutralizing | 3 | 2022 | 1936 | 0.160 |
Why?
|
Influenza A virus | 1 | 2022 | 458 | 0.160 |
Why?
|
Respiratory Mucosa | 1 | 2021 | 438 | 0.150 |
Why?
|
Genotype | 5 | 2021 | 12978 | 0.150 |
Why?
|
HIV Core Protein p24 | 1 | 2018 | 245 | 0.150 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2022 | 799 | 0.150 |
Why?
|
Taxoids | 2 | 2013 | 667 | 0.150 |
Why?
|
Interleukin-10 | 2 | 2014 | 1172 | 0.150 |
Why?
|
Antigens, CD | 4 | 2020 | 3998 | 0.140 |
Why?
|
Simian immunodeficiency virus | 2 | 2014 | 810 | 0.140 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2023 | 612 | 0.140 |
Why?
|
Autoantigens | 2 | 2020 | 888 | 0.140 |
Why?
|
Case-Control Studies | 6 | 2021 | 22148 | 0.140 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2019 | 610 | 0.140 |
Why?
|
Latent Tuberculosis | 2 | 2016 | 224 | 0.140 |
Why?
|
Depressive Disorder | 1 | 2009 | 3735 | 0.130 |
Why?
|
Neoplasm Metastasis | 5 | 2014 | 4910 | 0.130 |
Why?
|
Carcinoma, Lobular | 1 | 2020 | 480 | 0.130 |
Why?
|
Adult | 38 | 2023 | 220969 | 0.130 |
Why?
|
Scleroderma, Systemic | 1 | 2020 | 344 | 0.130 |
Why?
|
Male | 46 | 2024 | 360358 | 0.130 |
Why?
|
Alleles | 3 | 2022 | 6861 | 0.130 |
Why?
|
Immunoglobulin Fc Fragments | 2 | 2016 | 280 | 0.130 |
Why?
|
Immunoassay | 1 | 2019 | 744 | 0.130 |
Why?
|
Phagocytosis | 3 | 2018 | 1526 | 0.130 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 2 | 2011 | 541 | 0.120 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2019 | 825 | 0.120 |
Why?
|
Kaplan-Meier Estimate | 4 | 2020 | 6474 | 0.120 |
Why?
|
South Africa | 6 | 2017 | 1836 | 0.120 |
Why?
|
Carcinoma in Situ | 1 | 2020 | 791 | 0.120 |
Why?
|
Influenza Vaccines | 1 | 2022 | 767 | 0.120 |
Why?
|
Longitudinal Studies | 6 | 2022 | 14591 | 0.120 |
Why?
|
Contraceptive Agents, Female | 1 | 2015 | 118 | 0.120 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 2014 | 110 | 0.110 |
Why?
|
Progestins | 1 | 2015 | 301 | 0.110 |
Why?
|
Mitochondria | 3 | 2017 | 3619 | 0.110 |
Why?
|
Tourette Syndrome | 2 | 2007 | 395 | 0.110 |
Why?
|
Herpesviridae | 1 | 2014 | 104 | 0.110 |
Why?
|
Bayes Theorem | 1 | 2021 | 2326 | 0.110 |
Why?
|
Young Adult | 15 | 2021 | 59179 | 0.110 |
Why?
|
Lymphocyte Activation | 5 | 2016 | 5463 | 0.110 |
Why?
|
Macrophages | 3 | 2018 | 5758 | 0.110 |
Why?
|
Cervix Uteri | 1 | 2017 | 570 | 0.110 |
Why?
|
Algorithms | 3 | 2021 | 14018 | 0.100 |
Why?
|
Prevalence | 5 | 2021 | 15689 | 0.100 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2022 | 1080 | 0.100 |
Why?
|
Bacteria | 3 | 2024 | 2192 | 0.100 |
Why?
|
Bereavement | 2 | 2006 | 309 | 0.100 |
Why?
|
Carcinoma, Renal Cell | 3 | 2013 | 3164 | 0.100 |
Why?
|
Viruses | 1 | 2016 | 374 | 0.100 |
Why?
|
DNA Fingerprinting | 1 | 2011 | 114 | 0.100 |
Why?
|
Lipopolysaccharides | 1 | 2019 | 2202 | 0.100 |
Why?
|
Nucleotides | 1 | 2014 | 453 | 0.090 |
Why?
|
Middle Aged | 30 | 2023 | 220584 | 0.090 |
Why?
|
T-Lymphocytes | 3 | 2019 | 10175 | 0.090 |
Why?
|
Alphapapillomavirus | 1 | 2014 | 218 | 0.090 |
Why?
|
Antigen Presentation | 2 | 2014 | 1250 | 0.090 |
Why?
|
Carboplatin | 1 | 2014 | 793 | 0.090 |
Why?
|
Dendritic Cells | 2 | 2014 | 2722 | 0.090 |
Why?
|
Influenza, Human | 1 | 2022 | 1518 | 0.090 |
Why?
|
Autoantibodies | 1 | 2020 | 2115 | 0.090 |
Why?
|
Stavudine | 1 | 2010 | 85 | 0.090 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2013 | 11736 | 0.090 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2013 | 4020 | 0.090 |
Why?
|
Parental Consent | 1 | 2011 | 63 | 0.090 |
Why?
|
Kidney Neoplasms | 3 | 2013 | 4250 | 0.090 |
Why?
|
Flow Cytometry | 7 | 2017 | 5863 | 0.090 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2014 | 621 | 0.090 |
Why?
|
Antibodies, Bacterial | 1 | 2016 | 1463 | 0.090 |
Why?
|
Receptors, Natural Killer Cell | 1 | 2010 | 57 | 0.090 |
Why?
|
Carbonic Anhydrases | 1 | 2010 | 108 | 0.090 |
Why?
|
Nucleosides | 1 | 2010 | 131 | 0.090 |
Why?
|
Genetic Research | 1 | 2011 | 171 | 0.090 |
Why?
|
T-Lymphocyte Subsets | 2 | 2016 | 1798 | 0.090 |
Why?
|
Breast Neoplasms | 3 | 2022 | 20988 | 0.080 |
Why?
|
Protein Isoforms | 2 | 2011 | 1697 | 0.080 |
Why?
|
Antibodies, Viral | 3 | 2022 | 3150 | 0.080 |
Why?
|
Acidosis, Lactic | 1 | 2011 | 146 | 0.080 |
Why?
|
Mesenchymal Stem Cells | 1 | 2020 | 1642 | 0.080 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 3 | 2018 | 302 | 0.080 |
Why?
|
Immunity, Innate | 5 | 2016 | 3045 | 0.080 |
Why?
|
Phagocytes | 1 | 2011 | 295 | 0.080 |
Why?
|
Disease Progression | 6 | 2016 | 13495 | 0.080 |
Why?
|
Mucous Membrane | 3 | 2021 | 659 | 0.080 |
Why?
|
Adenoma, Oxyphilic | 1 | 2010 | 148 | 0.080 |
Why?
|
Lamivudine | 1 | 2010 | 366 | 0.080 |
Why?
|
Hepatitis C, Chronic | 2 | 2014 | 1018 | 0.080 |
Why?
|
B-Lymphocytes | 2 | 2019 | 4745 | 0.080 |
Why?
|
Zidovudine | 1 | 2010 | 624 | 0.080 |
Why?
|
Levamisole | 1 | 2008 | 35 | 0.080 |
Why?
|
Granzymes | 1 | 2010 | 277 | 0.080 |
Why?
|
Colorectal Neoplasms | 1 | 2008 | 6925 | 0.080 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2011 | 262 | 0.080 |
Why?
|
Autoimmune Diseases | 1 | 2020 | 2238 | 0.080 |
Why?
|
Natural Cytotoxicity Triggering Receptor 1 | 3 | 2014 | 29 | 0.080 |
Why?
|
Cross-Sectional Studies | 7 | 2021 | 26049 | 0.070 |
Why?
|
Adaptation, Psychological | 3 | 2008 | 2629 | 0.070 |
Why?
|
Immune Evasion | 1 | 2011 | 363 | 0.070 |
Why?
|
Virus Diseases | 1 | 2014 | 718 | 0.070 |
Why?
|
Hyperplasia | 2 | 2021 | 1150 | 0.070 |
Why?
|
Age Factors | 4 | 2013 | 18381 | 0.070 |
Why?
|
Lymphocyte Count | 4 | 2012 | 778 | 0.070 |
Why?
|
Endothelial Cells | 1 | 2020 | 3548 | 0.070 |
Why?
|
Truth Disclosure | 1 | 2011 | 432 | 0.070 |
Why?
|
Antigens, Differentiation | 1 | 2010 | 908 | 0.070 |
Why?
|
SAIDS Vaccines | 1 | 2008 | 144 | 0.070 |
Why?
|
Paclitaxel | 1 | 2014 | 1730 | 0.070 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 3204 | 0.070 |
Why?
|
Vaccines, DNA | 1 | 2008 | 283 | 0.070 |
Why?
|
Neonatal Screening | 1 | 2011 | 597 | 0.070 |
Why?
|
Minority Groups | 2 | 2023 | 1202 | 0.070 |
Why?
|
Immunophenotyping | 3 | 2016 | 1865 | 0.070 |
Why?
|
Camptothecin | 1 | 2009 | 591 | 0.060 |
Why?
|
Cocaine-Related Disorders | 1 | 2009 | 461 | 0.060 |
Why?
|
Bacterial Infections | 1 | 2014 | 1389 | 0.060 |
Why?
|
Lactic Acid | 1 | 2011 | 1139 | 0.060 |
Why?
|
Fatigue | 3 | 2022 | 1550 | 0.060 |
Why?
|
Carcinoma, Papillary | 1 | 2010 | 785 | 0.060 |
Why?
|
Gene Expression Regulation | 3 | 2021 | 11874 | 0.060 |
Why?
|
Child Abuse, Sexual | 1 | 2008 | 403 | 0.060 |
Why?
|
Monocytes | 1 | 2014 | 2565 | 0.060 |
Why?
|
Receptors, CCR5 | 2 | 2021 | 486 | 0.060 |
Why?
|
Dose-Response Relationship, Immunologic | 2 | 2016 | 360 | 0.060 |
Why?
|
Sample Size | 1 | 2008 | 838 | 0.060 |
Why?
|
Severity of Illness Index | 4 | 2022 | 15828 | 0.060 |
Why?
|
Quinolines | 1 | 2010 | 764 | 0.060 |
Why?
|
Smoking | 1 | 2021 | 9050 | 0.060 |
Why?
|
Treatment Outcome | 9 | 2020 | 64568 | 0.060 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 2 | 2021 | 306 | 0.060 |
Why?
|
Substance Abuse, Intravenous | 1 | 2009 | 529 | 0.060 |
Why?
|
Fibrosis | 2 | 2023 | 2045 | 0.060 |
Why?
|
Epidemiologic Methods | 1 | 2009 | 1335 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2021 | 4849 | 0.060 |
Why?
|
Viral Proteins | 1 | 2011 | 1799 | 0.060 |
Why?
|
Urban Population | 1 | 2012 | 2033 | 0.060 |
Why?
|
Chemotaxis | 2 | 2021 | 598 | 0.060 |
Why?
|
Imidazoles | 1 | 2010 | 1175 | 0.060 |
Why?
|
Cell Degranulation | 2 | 2018 | 277 | 0.060 |
Why?
|
Virus Replication | 3 | 2019 | 2427 | 0.060 |
Why?
|
Placebos | 1 | 2008 | 1667 | 0.060 |
Why?
|
Immunoglobulin D | 1 | 2023 | 54 | 0.050 |
Why?
|
Risk Factors | 6 | 2021 | 74115 | 0.050 |
Why?
|
Receptors, CXCR5 | 1 | 2023 | 88 | 0.050 |
Why?
|
Fluorouracil | 1 | 2008 | 1642 | 0.050 |
Why?
|
Sirolimus | 1 | 2010 | 1533 | 0.050 |
Why?
|
DNA | 2 | 2014 | 7196 | 0.050 |
Why?
|
Lymph Nodes | 2 | 2011 | 3461 | 0.050 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 2 | 2014 | 84 | 0.050 |
Why?
|
Antigens, Neoplasm | 1 | 2010 | 1985 | 0.050 |
Why?
|
Psychotherapy, Group | 1 | 2006 | 413 | 0.050 |
Why?
|
DNA, Viral | 2 | 2023 | 2195 | 0.050 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 2 | 2014 | 95 | 0.050 |
Why?
|
Disease Models, Animal | 3 | 2019 | 18221 | 0.050 |
Why?
|
Confidence Intervals | 1 | 2008 | 2925 | 0.050 |
Why?
|
Disease-Free Survival | 2 | 2014 | 6807 | 0.050 |
Why?
|
Vaccination | 1 | 2014 | 3370 | 0.050 |
Why?
|
Breast | 2 | 2021 | 1963 | 0.050 |
Why?
|
Interviews as Topic | 1 | 2009 | 2697 | 0.050 |
Why?
|
Multivariate Analysis | 2 | 2012 | 12043 | 0.050 |
Why?
|
Interleukin-2 | 3 | 2015 | 1887 | 0.050 |
Why?
|
Interferon-gamma | 3 | 2016 | 3145 | 0.050 |
Why?
|
Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2022 | 158 | 0.050 |
Why?
|
Cell Death | 3 | 2011 | 1677 | 0.050 |
Why?
|
Medication Adherence | 2 | 2023 | 2174 | 0.050 |
Why?
|
Immunologic Memory | 1 | 2008 | 1355 | 0.050 |
Why?
|
Aged | 15 | 2021 | 169042 | 0.050 |
Why?
|
Chemokine CCL5 | 1 | 2021 | 214 | 0.050 |
Why?
|
HIV Seropositivity | 1 | 2006 | 959 | 0.050 |
Why?
|
Socioeconomic Factors | 2 | 2017 | 7798 | 0.050 |
Why?
|
Polypharmacy | 1 | 2023 | 286 | 0.040 |
Why?
|
Antibody Specificity | 2 | 2014 | 1058 | 0.040 |
Why?
|
Receptors, CXCR3 | 1 | 2021 | 238 | 0.040 |
Why?
|
Metronidazole | 1 | 2022 | 232 | 0.040 |
Why?
|
Hepatitis C | 1 | 2010 | 1579 | 0.040 |
Why?
|
Macaca mulatta | 3 | 2014 | 2328 | 0.040 |
Why?
|
Intestinal Mucosa | 1 | 2011 | 3031 | 0.040 |
Why?
|
DNA, Mitochondrial | 2 | 2017 | 865 | 0.040 |
Why?
|
Chemokine CXCL10 | 1 | 2021 | 309 | 0.040 |
Why?
|
Hypoglycemic Agents | 1 | 2013 | 3085 | 0.040 |
Why?
|
Social Behavior | 1 | 2007 | 1135 | 0.040 |
Why?
|
Cohort Studies | 7 | 2018 | 41457 | 0.040 |
Why?
|
Drug Administration Schedule | 3 | 2013 | 4845 | 0.040 |
Why?
|
Interleukin-18 | 1 | 2021 | 250 | 0.040 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2008 | 3514 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2010 | 3705 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2008 | 6224 | 0.040 |
Why?
|
Reagent Strips | 1 | 2019 | 40 | 0.040 |
Why?
|
HIV Envelope Protein gp120 | 2 | 2016 | 914 | 0.040 |
Why?
|
Aminoimidazole Carboxamide | 1 | 2019 | 85 | 0.040 |
Why?
|
United States | 6 | 2023 | 72272 | 0.040 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2021 | 755 | 0.040 |
Why?
|
Survival Analysis | 2 | 2011 | 10073 | 0.040 |
Why?
|
Child, Preschool | 2 | 2020 | 42188 | 0.040 |
Why?
|
Caregivers | 1 | 2011 | 2241 | 0.040 |
Why?
|
Administration, Intranasal | 2 | 2013 | 476 | 0.040 |
Why?
|
Population Surveillance | 1 | 2009 | 2595 | 0.040 |
Why?
|
Liver | 1 | 2014 | 7512 | 0.040 |
Why?
|
5'-Nucleotidase | 1 | 2019 | 161 | 0.040 |
Why?
|
Child | 6 | 2020 | 80079 | 0.040 |
Why?
|
HLA-DR Antigens | 1 | 2020 | 602 | 0.040 |
Why?
|
Insulin | 1 | 2013 | 6593 | 0.040 |
Why?
|
Inflammation | 3 | 2023 | 10760 | 0.040 |
Why?
|
Hormones | 1 | 2022 | 869 | 0.040 |
Why?
|
GPI-Linked Proteins | 1 | 2019 | 469 | 0.040 |
Why?
|
Herpesvirus 4, Human | 1 | 2023 | 1077 | 0.040 |
Why?
|
Antigen-Presenting Cells | 1 | 2021 | 963 | 0.040 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2007 | 1491 | 0.040 |
Why?
|
Immune Tolerance | 1 | 2006 | 2299 | 0.040 |
Why?
|
Time Factors | 7 | 2015 | 39913 | 0.040 |
Why?
|
Cysteine | 1 | 2022 | 891 | 0.040 |
Why?
|
Adolescent | 10 | 2016 | 88234 | 0.030 |
Why?
|
Animals | 10 | 2022 | 168201 | 0.030 |
Why?
|
Prevotella | 1 | 2017 | 80 | 0.030 |
Why?
|
Bacteria, Anaerobic | 1 | 2017 | 70 | 0.030 |
Why?
|
Cytochromes c | 1 | 2017 | 173 | 0.030 |
Why?
|
Mice | 6 | 2022 | 81368 | 0.030 |
Why?
|
HIV Enteropathy | 1 | 2016 | 4 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2017 | 254 | 0.030 |
Why?
|
T-Cell Antigen Receptor Specificity | 1 | 2016 | 84 | 0.030 |
Why?
|
Alcohol Drinking | 1 | 2009 | 4025 | 0.030 |
Why?
|
Central Nervous System | 1 | 2023 | 1333 | 0.030 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2019 | 597 | 0.030 |
Why?
|
Educational Status | 1 | 2023 | 2509 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2019 | 1162 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2018 | 18937 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1088 | 0.030 |
Why?
|
Interleukin-15 | 1 | 2016 | 185 | 0.030 |
Why?
|
Lectins, C-Type | 2 | 2010 | 584 | 0.030 |
Why?
|
Cognition | 1 | 2013 | 6987 | 0.030 |
Why?
|
RNA, Viral | 2 | 2015 | 2838 | 0.030 |
Why?
|
Genetic Variation | 3 | 2016 | 6561 | 0.030 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 899 | 0.030 |
Why?
|
Immunization | 1 | 2019 | 1217 | 0.030 |
Why?
|
Down-Regulation | 2 | 2014 | 2915 | 0.030 |
Why?
|
Acute Disease | 2 | 2019 | 7237 | 0.030 |
Why?
|
Protein Array Analysis | 1 | 2016 | 399 | 0.030 |
Why?
|
Schools | 1 | 2023 | 1483 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2016 | 6074 | 0.030 |
Why?
|
Sequence Analysis | 1 | 2015 | 240 | 0.030 |
Why?
|
Nucleotide Transport Proteins | 1 | 2014 | 3 | 0.030 |
Why?
|
Cryptococcus | 1 | 2014 | 28 | 0.030 |
Why?
|
Infant, Newborn | 3 | 2021 | 26180 | 0.030 |
Why?
|
Schizophrenia | 1 | 2013 | 6929 | 0.030 |
Why?
|
Perforin | 1 | 2014 | 166 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2017 | 943 | 0.030 |
Why?
|
Grief | 2 | 2006 | 254 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2021 | 1614 | 0.030 |
Why?
|
HIV Envelope Protein gp41 | 1 | 2015 | 303 | 0.030 |
Why?
|
Neisseria meningitidis | 1 | 2014 | 108 | 0.030 |
Why?
|
JC Virus | 1 | 2014 | 87 | 0.030 |
Why?
|
Toxoplasmosis | 1 | 2014 | 94 | 0.030 |
Why?
|
Biological Evolution | 1 | 2019 | 1070 | 0.030 |
Why?
|
Karnofsky Performance Status | 1 | 2013 | 166 | 0.030 |
Why?
|
Pancreas | 1 | 2020 | 1690 | 0.030 |
Why?
|
Macrophage Activation | 1 | 2016 | 552 | 0.030 |
Why?
|
DNA, Protozoan | 1 | 2014 | 228 | 0.030 |
Why?
|
Students | 1 | 2023 | 1733 | 0.030 |
Why?
|
Glycosylation | 1 | 2016 | 1098 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2020 | 80566 | 0.030 |
Why?
|
Cryptococcosis | 1 | 2014 | 103 | 0.030 |
Why?
|
Receptors, IgG | 1 | 2016 | 558 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2016 | 587 | 0.030 |
Why?
|
Cell Line, Transformed | 1 | 2014 | 866 | 0.030 |
Why?
|
Africa | 1 | 2015 | 710 | 0.030 |
Why?
|
DNA, Fungal | 1 | 2014 | 275 | 0.030 |
Why?
|
Toxoplasma | 1 | 2014 | 157 | 0.030 |
Why?
|
Pregnancy | 3 | 2021 | 29868 | 0.030 |
Why?
|
Injections | 1 | 2015 | 832 | 0.030 |
Why?
|
Protein Stability | 1 | 2014 | 578 | 0.030 |
Why?
|
Leukopenia | 1 | 2013 | 213 | 0.030 |
Why?
|
Biodiversity | 1 | 2015 | 345 | 0.030 |
Why?
|
Contraception | 1 | 2015 | 347 | 0.030 |
Why?
|
Genome, Viral | 1 | 2016 | 665 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2009 | 7847 | 0.030 |
Why?
|
Gene Expression Profiling | 2 | 2021 | 9417 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2008 | 7995 | 0.020 |
Why?
|
Prostate | 1 | 2020 | 1773 | 0.020 |
Why?
|
Polymorphism, Genetic | 2 | 2013 | 4242 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2017 | 1134 | 0.020 |
Why?
|
Receptors, Interleukin-8A | 1 | 2011 | 47 | 0.020 |
Why?
|
Demography | 2 | 2007 | 1643 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2016 | 868 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2021 | 3206 | 0.020 |
Why?
|
Lymphopenia | 1 | 2013 | 281 | 0.020 |
Why?
|
Peptide Hydrolases | 1 | 2014 | 624 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2007 | 4488 | 0.020 |
Why?
|
Survivors | 1 | 2022 | 2372 | 0.020 |
Why?
|
Natural Cytotoxicity Triggering Receptor 3 | 1 | 2010 | 14 | 0.020 |
Why?
|
Cytosol | 1 | 2014 | 886 | 0.020 |
Why?
|
Deoxycytidine Kinase | 1 | 2010 | 11 | 0.020 |
Why?
|
Polyphosphates | 1 | 2010 | 17 | 0.020 |
Why?
|
Mice, SCID | 1 | 2016 | 2625 | 0.020 |
Why?
|
Uganda | 1 | 2016 | 1332 | 0.020 |
Why?
|
Cryopreservation | 1 | 2016 | 728 | 0.020 |
Why?
|
Toll-Like Receptors | 1 | 2014 | 575 | 0.020 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2015 | 1033 | 0.020 |
Why?
|
Prospective Studies | 4 | 2019 | 54360 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2020 | 2160 | 0.020 |
Why?
|
HLA-A Antigens | 1 | 2011 | 223 | 0.020 |
Why?
|
Gene Expression | 2 | 2016 | 7568 | 0.020 |
Why?
|
Public Opinion | 1 | 2014 | 484 | 0.020 |
Why?
|
HIV Long-Term Survivors | 1 | 2011 | 121 | 0.020 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2014 | 484 | 0.020 |
Why?
|
Biomarkers, Pharmacological | 1 | 2011 | 161 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2019 | 14648 | 0.020 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2014 | 563 | 0.020 |
Why?
|
Receptors, KIR2DL1 | 1 | 2010 | 13 | 0.020 |
Why?
|
Ethics, Clinical | 1 | 2011 | 101 | 0.020 |
Why?
|
Cytokines | 2 | 2016 | 7373 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2015 | 4341 | 0.020 |
Why?
|
Gene Products, gag | 1 | 2011 | 312 | 0.020 |
Why?
|
Viral Envelope Proteins | 1 | 2014 | 640 | 0.020 |
Why?
|
Mammography | 1 | 2021 | 2430 | 0.020 |
Why?
|
Lymphoid Tissue | 1 | 2012 | 445 | 0.020 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2011 | 192 | 0.020 |
Why?
|
Blood Banks | 1 | 2011 | 108 | 0.020 |
Why?
|
Thymidine Kinase | 1 | 2010 | 286 | 0.020 |
Why?
|
Antigens, Surface | 1 | 2014 | 1605 | 0.020 |
Why?
|
Interleukins | 1 | 2015 | 783 | 0.020 |
Why?
|
Haplotypes | 1 | 2016 | 2713 | 0.020 |
Why?
|
Genes, T-Cell Receptor beta | 1 | 2010 | 70 | 0.020 |
Why?
|
Recurrence | 2 | 2014 | 8426 | 0.020 |
Why?
|
Epithelial Cells | 2 | 2014 | 3672 | 0.020 |
Why?
|
Polysaccharides | 1 | 2016 | 1013 | 0.020 |
Why?
|
Trust | 1 | 2014 | 528 | 0.020 |
Why?
|
HIV Seronegativity | 1 | 2010 | 211 | 0.020 |
Why?
|
Myristic Acids | 1 | 2009 | 49 | 0.020 |
Why?
|
Gene Dosage | 1 | 2014 | 1217 | 0.020 |
Why?
|
Aged, 80 and over | 4 | 2020 | 58894 | 0.020 |
Why?
|
Cell Fusion | 1 | 2010 | 294 | 0.020 |
Why?
|
Cell Movement | 2 | 2011 | 5200 | 0.020 |
Why?
|
Gene Frequency | 1 | 2016 | 3601 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2013 | 1739 | 0.020 |
Why?
|
Glucuronosyltransferase | 1 | 2009 | 132 | 0.020 |
Why?
|
Proteome | 1 | 2019 | 1857 | 0.020 |
Why?
|
K562 Cells | 1 | 2010 | 641 | 0.020 |
Why?
|
DNA, Bacterial | 1 | 2014 | 1471 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2015 | 12447 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2013 | 571 | 0.020 |
Why?
|
Interleukin-17 | 1 | 2015 | 911 | 0.020 |
Why?
|
Blood Donors | 1 | 2011 | 345 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2015 | 1404 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2013 | 2214 | 0.020 |
Why?
|
Streptococcus pneumoniae | 1 | 2014 | 730 | 0.020 |
Why?
|
Point Mutation | 1 | 2013 | 1595 | 0.020 |
Why?
|
Phylogeny | 1 | 2016 | 2806 | 0.020 |
Why?
|
Receptors, Chemokine | 1 | 2011 | 652 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 2014 | 1550 | 0.020 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2014 | 1320 | 0.020 |
Why?
|
Kinetics | 1 | 2015 | 6370 | 0.020 |
Why?
|
ras Proteins | 1 | 2013 | 1054 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2010 | 1703 | 0.020 |
Why?
|
Hypotension | 1 | 2013 | 878 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 2016 | 1880 | 0.020 |
Why?
|
Glucose | 1 | 2019 | 4345 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12719 | 0.020 |
Why?
|
Transcription Factors | 2 | 2021 | 12116 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2016 | 1884 | 0.020 |
Why?
|
Cyclooxygenase 2 | 1 | 2009 | 596 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9529 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2021 | 3194 | 0.020 |
Why?
|
Pain | 1 | 2022 | 5061 | 0.020 |
Why?
|
Wisconsin | 1 | 2006 | 122 | 0.020 |
Why?
|
Boronic Acids | 1 | 2011 | 915 | 0.020 |
Why?
|
History, 20th Century | 1 | 2014 | 2764 | 0.020 |
Why?
|
Injections, Intramuscular | 1 | 2008 | 555 | 0.020 |
Why?
|
Chronic Disease | 2 | 2012 | 9311 | 0.020 |
Why?
|
Hospitals, Teaching | 1 | 2011 | 1155 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2010 | 2010 | 0.020 |
Why?
|
Quinazolines | 1 | 2013 | 1371 | 0.020 |
Why?
|
Clone Cells | 1 | 2010 | 1657 | 0.020 |
Why?
|
Family Characteristics | 1 | 2011 | 992 | 0.020 |
Why?
|
Vaccinia virus | 1 | 2008 | 329 | 0.020 |
Why?
|
Virulence | 1 | 2010 | 1299 | 0.020 |
Why?
|
Diarrhea | 1 | 2013 | 1317 | 0.020 |
Why?
|
HLA Antigens | 1 | 2011 | 1329 | 0.020 |
Why?
|
Schizophrenic Psychology | 1 | 2013 | 1646 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2013 | 39063 | 0.020 |
Why?
|
Blood Cell Count | 1 | 2006 | 397 | 0.020 |
Why?
|
Tic Disorders | 1 | 2006 | 136 | 0.020 |
Why?
|
Canada | 1 | 2011 | 2118 | 0.020 |
Why?
|
Interleukin-12 | 1 | 2008 | 577 | 0.020 |
Why?
|
Diagnostic Tests, Routine | 1 | 2011 | 786 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2008 | 13635 | 0.020 |
Why?
|
Mucin-1 | 1 | 2010 | 538 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2013 | 1745 | 0.020 |
Why?
|
Psychology | 1 | 2007 | 356 | 0.020 |
Why?
|
Pyrazines | 1 | 2011 | 1202 | 0.020 |
Why?
|
Immunity, Mucosal | 1 | 2008 | 483 | 0.010 |
Why?
|
Quality of Life | 2 | 2022 | 13347 | 0.010 |
Why?
|
Immunoglobulin A | 1 | 2008 | 978 | 0.010 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2006 | 897 | 0.010 |
Why?
|
Cell Proliferation | 2 | 2010 | 10432 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2016 | 3567 | 0.010 |
Why?
|
Doxorubicin | 1 | 2011 | 2224 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2011 | 1742 | 0.010 |
Why?
|
New York | 1 | 2006 | 874 | 0.010 |
Why?
|
Liver Cirrhosis | 1 | 2014 | 1926 | 0.010 |
Why?
|
Multiprotein Complexes | 1 | 2010 | 1118 | 0.010 |
Why?
|
Mice, Nude | 1 | 2010 | 3605 | 0.010 |
Why?
|
Risk | 1 | 2015 | 9604 | 0.010 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2011 | 1250 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2014 | 3688 | 0.010 |
Why?
|
Neutrophils | 1 | 2016 | 3763 | 0.010 |
Why?
|
Cell Line, Tumor | 2 | 2010 | 16967 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2011 | 4110 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2013 | 9277 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2013 | 6016 | 0.010 |
Why?
|
Gene Silencing | 1 | 2009 | 1503 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2014 | 13441 | 0.010 |
Why?
|
Models, Psychological | 1 | 2007 | 829 | 0.010 |
Why?
|
Adjuvants, Immunologic | 1 | 2008 | 990 | 0.010 |
Why?
|
Peptides | 1 | 2014 | 4354 | 0.010 |
Why?
|
Prognosis | 2 | 2014 | 29600 | 0.010 |
Why?
|
Cancer Vaccines | 1 | 2010 | 1037 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2011 | 2546 | 0.010 |
Why?
|
Attitude to Health | 1 | 2011 | 2024 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2021 | 15908 | 0.010 |
Why?
|
Streptococcal Infections | 1 | 2006 | 617 | 0.010 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2010 | 3599 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2013 | 10754 | 0.010 |
Why?
|
Health Education | 1 | 2008 | 1049 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2010 | 2057 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2019 | 20074 | 0.010 |
Why?
|
Seizures | 1 | 2014 | 2954 | 0.010 |
Why?
|
Cell Cycle | 1 | 2009 | 2930 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2013 | 4512 | 0.010 |
Why?
|
Biopsy | 1 | 2011 | 6762 | 0.010 |
Why?
|
Antipsychotic Agents | 1 | 2013 | 3066 | 0.010 |
Why?
|
Age of Onset | 1 | 2006 | 3302 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2014 | 11116 | 0.010 |
Why?
|
Cell Survival | 1 | 2009 | 5780 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2009 | 2801 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2016 | 9172 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2013 | 12334 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2009 | 3492 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20556 | 0.010 |
Why?
|
Phosphorylation | 1 | 2009 | 8311 | 0.010 |
Why?
|
Incidence | 1 | 2015 | 21337 | 0.010 |
Why?
|
Sex Factors | 1 | 2010 | 10548 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2006 | 2689 | 0.010 |
Why?
|
Phenotype | 1 | 2014 | 16571 | 0.010 |
Why?
|
Proteins | 1 | 2010 | 6030 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2011 | 4308 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2009 | 5789 | 0.010 |
Why?
|
Mutation | 1 | 2019 | 30016 | 0.010 |
Why?
|
Body Mass Index | 1 | 2011 | 12943 | 0.010 |
Why?
|
Models, Biological | 1 | 2009 | 9461 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2009 | 9586 | 0.010 |
Why?
|
Mass Screening | 1 | 2006 | 5424 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2006 | 10199 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2011 | 13382 | 0.000 |
Why?
|